Home Healthcare Healthcare IT Digital Pills Market

Digital Pills Market Size, Share & Trends Analysis Report By Indicated Disorders (Tracking Ingestion in Schizophrenia Patients, Tracking Ingestion in Bipolar Patients, Adjunctive treatment of MDD (major depressive disorder) in adults), By End-Users (Hospitals, Clinic, Home Care Settings) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 28, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Digital Pills Market, By Indicated Disorders 2022-2034 (USD MILLION/ Units)
    1. Tracking Ingestion in Schizophrenia Patients
    2. Tracking Ingestion in Bipolar Patients
    3. Adjunctive treatment of MDD (major depressive disorder) in adults
  2. Digital Pills Market, By End-Users 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Clinic
    3. Home Care Settings
  3. Regional Digital Pills Market
    1. North America
      1. North America Digital Pills Market By Indicated Disorders 2022-2034 (USD MILLION/ Units)
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
      2. North America Digital Pills Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinic
        3. Home Care Settings
      3. U.S.
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      4. Canada
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
    2. Europe
      1. Europe Digital Pills Market By Indicated Disorders 2022-2034 (USD MILLION/ Units)
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
      2. Europe Digital Pills Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinic
        3. Home Care Settings
      3. U.K.
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      4. Germany
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      5. France
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      6. Spain
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      7. Italy
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      8. Russia
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      9. Nordic
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      10. Benelux
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      11. Rest of Europe
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
    3. APAC
      1. APAC Digital Pills Market By Indicated Disorders 2022-2034 (USD MILLION/ Units)
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
      2. APAC Digital Pills Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinic
        3. Home Care Settings
      3. China
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      4. Korea
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      5. Japan
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      6. India
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      7. Australia
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      8. Taiwan
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      9. South East Asia
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      10. Rest of Asia-Pacific
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
    4. Middle East and Africa
      1. Middle East and Africa Digital Pills Market By Indicated Disorders 2022-2034 (USD MILLION/ Units)
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
      2. Middle East and Africa Digital Pills Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinic
        3. Home Care Settings
      3. UAE
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      4. Turkey
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      5. Saudi Arabia
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      6. South Africa
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      7. Egypt
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      8. Nigeria
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      9. Rest of MEA
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
    5. LATAM
      1. LATAM Digital Pills Market By Indicated Disorders 2022-2034 (USD MILLION/ Units)
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
      2. LATAM Digital Pills Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinic
        3. Home Care Settings
      3. Brazil
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      4. Mexico
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      5. Argentina
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      6. Chile
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      7. Colombia
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
      8. Rest of LATAM
        1. Tracking Ingestion in Schizophrenia Patients
        2. Tracking Ingestion in Bipolar Patients
        3. Adjunctive treatment of MDD (major depressive disorder) in adults
        4. Hospitals
        5. Clinic
        6. Home Care Settings
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.